Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-004482-33Phase 2Active
Phase 2 trial of dronabinol in cannabis use disorder (CUD), sponsored by University Medical Center Utrecht. Primary endpoints: Premature study termination due to safety concerns and Acute effects of THC on brain functional systems. Started Jan 2007; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-004482-33.